Search Results - "Xiros, N"

Virtual damper–spring system for VIV experiments and hydrokinetic energy conversion by Lee, J.H., Xiros, N., Bernitsas, M.M.

“…A device/system V CK is built to replace the physical damper/springs of the VIVACE Converter with virtual elements. VIVACE harnesses hydrokinetic energy of…”
Get full text

Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter, Randomized, Phase III Study From the Hellenic Cooperative Oncology Group by BAMIAS, A, ARAVANTINOS, G, PAPAKASTAS, P, GIKA, D, KOUROUSIS, C, KOUTRAS, A, PAPADIMITRIOU, C, BAMIAS, C, KOSMIDIS, P, DIMOPOULOS, M. A, DELIVELIOTIS, C, BAFALOUKOS, D, KALOFONOS, C, XIROS, N, ZERVAS, A, MITROPOULOS, D, SAMANTAS, E, PECTASIDES, D

“…The combination of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) represents the standard regimen for inoperable or metastatic urothelial cancer,…”
Get full text

Carboplatin and paclitaxel in advanced or metastatic endometrial cancer by Pectasides, D, Xiros, N, Papaxoinis, G, Pectasides, E, Sykiotis, C, Koumarianou, A, Psyrri, A, Gaglia, A, Kassanos, D, Gouveris, P, Panayiotidis, J, Fountzilas, G, Economopoulos, T

“…Abstract Objectives The purpose of this study was to evaluate the activity and toxicity of carboplatin and paclitaxel combination in advanced or recurrent…”
Get full text

Comparison of docetaxel and docetaxel–irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial by Pectasides, D., Pectasides, M., Farmakis, D., Kostopoulou, V., Nikolaou, M., Gaglia, A., Koumpou, M., Mylonakis, N., Xiros, N., Economopoulos, T., Raptis, S. A.

“…Background: The aim of this study was to evaluate whether docetaxel (taxotere) treatment with or without irinotecan improved patient outcomes with similar…”
Get full text

Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG) by Papaxoinis, G., Fountzilas, G., Rontogianni, D., Dimopoulos, M. A., Pavlidis, N., Tsatalas, C., Pectasides, D., Xiros, N., Economopoulos, T.

“…Background: The aim was to examine characteristics and treatment results of patients with mucosa-associated lymphoid tissue (MALT) non-Hodgkin's lymphomas…”
Get full text

Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group by Kosmidis, P. A., Kalofonos, H. P., Christodoulou, C., Syrigos, K., Makatsoris, T., Skarlos, D., Bakogiannis, C., Nicolaides, C., Bafaloukos, D., Bamias, A., Samantas, E., Xiros, N., Boukovinas, I., Fountzilas, G., Dimopoulos, M. A.

“…Background: This phase III study was designed to compare the combination paclitaxel (Taxol)–gemcitabine (PG) versus carboplatin–gemcitabine (CG) in patients…”
Get full text

Let-7, MiR-98 and MiR-181 as Biomarkers for Cancer and Schizophrenia by Rizos, E, Siafakas, N, Papageorgiou, C.H, Katsantoni, E, Skourti, E, Salpeas, V, Rizos, I, Tsoporis, J.N, Parker, T.G, Xiros, N, Kastania, A, Zoumpourlis, V

“…Backround Recent studies support an important role of microRNAs in cancer and major psychiatric disorders, through their regulotory role on the expression of…”
Get full text

Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00 by Fountzilas, G., Dafni, U., Gogas, H., Linardou, H., Kalofonos, H. P., Briasoulis, E., Pectasides, D., Samantas, E., Bafaloukos, D., Stathopoulos, G. P., Karina, M., Papadimitriou, C., Skarlos, D., Pisanidis, N., Papakostas, P., Markopoulos, C., Tzorakoeleftherakis, E., Dimitrakakis, K., Makrantonakis, P., Xiros, N., Polichronis, A., Varthalitis, I., Karanikiotis, C., Dimopoulos, A. M.

“…Background: A randomized phase III trial in high-risk breast cancer patients was conducted, to further explore the impact of dose-density in the adjuvant…”
Get full text

Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy by ARGYRIOU, A.A., POLYCHRONOPOULOS, P., KOUTRAS, A., XIROS, N., PETSAS, T., ARGYRIOU, K., KALOFONOS, H.P., CHRONI, E.

“…The current prospective study sought to trace the incidence and severity of cisplatin plus paclitaxel (DDP+P)‐induced neuropathy and to determine its clinical…”
Get full text

Carboplatin/gemcitabine alternating with carboplatin/pegylated liposomal doxorubicin and carboplatin/cyclophosphamide in platinum-refractory/resistant paclitaxel — pretreated ovarian carcinoma by Pectasides, D, Pectasides, E, Papaxoinis, G, Psyrri, A, Pliarchopoulou, K, Koumarianou, A, Macheras, A, Athanasas, G, Xiros, N, Economopoulos, T

“…Abstract Objective In this phase II study the efficacy and toxicity of an alternating chemotherapy regimen was examined in platinum-resistant relapsed…”
Get full text

Performance evaluation of the Abbott CELL-DYN Emerald for use as a bench-top analyzer in a research setting by Khoo, T.-L., Xiros, N., Guan, F., Orellana, D., Holst, J., Joshua, D. E., Rasko, J. E. J.

“…Summary Introduction The CELL‐DYN Emerald is a compact bench‐top hematology analyzer that can be used for a three‐part white cell differential analysis. To…”
Get full text

A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1/IRF4 by Valsami, Serena, Pappa, Vassiliki, Rontogianni, Dimitra, Kontsioti, Frieda, Papageorgiou, Efstathios, Dervenoulas, John, Karmiris, Themis, Papageorgiou, Sotirios, Harhalakis, Nikolaos, Xiros, Nikolaos, Nikiforakis, Emmanuel, Economopoulos, Theofanis

“…From the Second Department of Internal Medicine, Attikon University General Hospital, Haidari, Athens, Greece (SV, VP, FK, EP, JD, SP, NX, TE); Pathology…”
Get full text

Survival Improvement of Young Patients, Aged 16-23, with Hodgkin Lymphoma (HL) during the Last Three Decades by KOUMARIANOU, A. A, XIROS, N, PAPAGEORGIOU, E, PECTASIDES, D, ECONOMOPOULOS, T

“…The prognostic factors, treatments and outcomes of 55 young adults (16-23 years old) with Hodgkin lymphoma (HL) treated in the Second Department of Internal…”
Get full text

Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study by Briasoulis, E., Fountzilas, G., Bamias, A., Dimopoulos, M. A., Xiros, N., Aravantinos, G., Samantas, E., Kalofonos, H., Makatsoris, T., Mylonakis, N., Papakostas, P., Skarlos, D., Varthalitis, I., Pavlidis, N.

“…Background Cancer of unknown primary (CUP) lacks established therapy although it affects 3% of cancer patients. We evaluated the irinotecan–oxaliplatin…”
Get full text

Cisplatin-Based Chemotherapy for Merkel Cell Carcinoma of the Skin by Pectasides, D., Pectasides, M., Psyrri, A., Koumarianou, A., Xiros, N., Pectasides, E., Gaglia, A., Lianos, E., Papaxoinis, G., Lampadiari, V., Economopoulos, Th

“…Purpose: Merkel cell carcinoma (MCC), a rare tumor of the skin with aggressive behavior, is usually fatal when advanced disease is present. The role of…”
Get full text

Monoclonal gammopathies in B-cell non-Hodgkin’s lymphomas by Economopoulos, T, Papageorgiou, S, Pappa, V, Papageorgiou, E, Valsami, S, Kalantzis, D, Xiros, N, Dervenoulas, J, Raptis, S

“…The association of monoclonal gammopathy (MG) with B-cell non-Hodgkin’s lymphomas (NHL) is a well known phenomenon. The aim of the present work was to study…”
Get full text

Microvessel Density (MVD) and Cyclooxygenase-2 (COX-2)/ β-Catenin Interaction Are Associated with Relapse in Patients with Transitional Carcinoma Receiving Adjuvant Chemotherapy with Paclitaxel/Carboplatin : A Hellenic Cooperative Oncology Group (HECOG) Study by BAMIAS, A, KYRIAKOU, F, MURRAY, S, TAMVAKIS, N, DIMOPOULOS, M. A, CHORTI, M, KAVANTZAS, N, NONI, A, KYROUDI-VOULGARI, A, RONTOYIANNI, D, KASTRITIS, E, XIROS, N, PATSOURIS, E. S

“…Cycloxygenase (COX)-2 has been associated with proliferation, apoptosis and angiogenesis in urothelial cancer. The prognostic significance of COX-2 in patients…”
Get full text

Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group by Xiros, N., Papacostas, P., Economopoulos, T., Samelis, G., Efstathiou, E., Kastritis, E., Kalofonos, H., Onyenadum, A., Skarlos, D., Bamias, A., Gogas, H., Bafaloukos, D., Samantas, E., Kosmidis, P.

“…Background:: In the present phase II multicenter study, we assessed the efficacy and tolerability of the combination of gemcitabine and carboplatin in patients…”
Get full text

CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology Group by Economopoulos, T, Psyrri, A, Dimopoulos, M A, Kalogera-Fountzila, A, Pavlidis, N, Tsatalas, C, Nikolaides, C, Mellou, S, Xiros, N, Fountzilas, G

“…In this study we investigated whether administering CEOP (cyclophosphamide, epirubicin, vincristine [Oncovin], and prednisone) every 2 weeks (CEOP-14) instead…”
Get full text

PID marine engine speed regulation under full load conditions for sensitivity H∞-norm specifications against propeller disturbance by Xiros, N I

“…An improved PID tuning method is proposed for marine diesel engine governors which may encounter significant problems, under severe propeller load fluctuation…”
Get full text